{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:34:26Z","timestamp":1786995266769,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","award":["U01FD005942"],"award-info":[{"award-number":["U01FD005942"]}],"id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Glaucoma"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.ogla.2019.07.005","type":"journal-article","created":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T02:39:56Z","timestamp":1564540796000},"page":"374-382","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Identifying Outcomes That Are Important to Patients with Ocular Hypertension or Primary Open-Angle Glaucoma"],"prefix":"10.1016","volume":"2","author":[{"given":"Jimmy T.","family":"Le","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kareshma","family":"Mohanty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda K.","family":"Bicket","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle E.","family":"Tarver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malvina B.","family":"Eydelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianjing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ogla.2019.07.005_bib1","series-title":"Primary Open-Angle Glaucoma Preferred Practice Patterns","year":"2010"},{"key":"10.1016\/j.ogla.2019.07.005_bib2","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1001\/archopht.122.4.532","article-title":"Prevalence of open-angle glaucoma among adults in the United States","volume":"122","author":"Friedman","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ogla.2019.07.005_bib3","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/bjo.2005.081224","article-title":"The number of people with glaucoma worldwide in 2010 and 2020","volume":"90","author":"Quigley","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ogla.2019.07.005_bib4","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1136\/bjophthalmol-2014-305550","article-title":"Biomarkers and surrogate endpoints in glaucoma clinical trials","volume":"99","author":"Medeiros","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ogla.2019.07.005_bib5","article-title":"Incorporating patients\u2019 perspectives","author":"Tarver","year":"2017","journal-title":"Glaucoma Today"},{"key":"10.1016\/j.ogla.2019.07.005_bib6","unstructured":"Food and Drug Administration. Guidance for industry patient preference information\u2014voluntary submission, review in premarket approval applications, humanitarian device exemption applications, and de novo requests, and inclusion in decision summaries and device labeling. 2016. Available at: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/patient-preference-information-voluntary-submission-review-premarket-approval-applications."},{"key":"10.1016\/j.ogla.2019.07.005_bib7","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1001\/jamaophthalmol.2016.2101","article-title":"Assessment of the incorporation of patient-centric outcomes in studies of minimally invasive glaucoma surgical devices","volume":"134","author":"Le","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ogla.2019.07.005_bib8","doi-asserted-by":"crossref","first-page":"xii","DOI":"10.1016\/j.ajo.2016.09.020","article-title":"From the patient\u2019s point of view, how should minimally invasive glaucoma surgeries be evaluated?","volume":"172","author":"Cui","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ogla.2019.07.005_bib9","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1136\/bmj.315.7123.1636","article-title":"Choosing the best research design for each question","volume":"315","author":"Sackett","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.ogla.2019.07.005_bib10","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/bmj.311.6996.42","article-title":"Reaching the parts other methods cannot reach: an introduction to qualitative methods in health and health services research","volume":"311","author":"Pope","year":"1995","journal-title":"BMJ"},{"key":"10.1016\/j.ogla.2019.07.005_bib11","series-title":"Analysing Qualitative Data","first-page":"173","article-title":"Qualitative data analysis for applied policy research","author":"Ritchie","year":"1993"},{"key":"10.1016\/j.ogla.2019.07.005_bib12","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1097\/ACM.0000000000000388","article-title":"Standards for reporting qualitative research: a synthesis of recommendations","volume":"89","author":"O\u2019Brien","year":"2014","journal-title":"Acad Med"},{"key":"10.1016\/j.ogla.2019.07.005_bib13","doi-asserted-by":"crossref","first-page":"a1035","DOI":"10.1136\/bmj.a1035","article-title":"Critically appraising qualitative research","volume":"337","author":"Kuper","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.ogla.2019.07.005_bib14","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/bmj.320.7227.114","article-title":"Qualitative research in health care. Analysing qualitative data","volume":"320","author":"Pope","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.ogla.2019.07.005_bib15","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/IJG.0b013e318287ac11","article-title":"Identifying content for the glaucoma-specific item bank to measure quality-of-life parameters","volume":"24","author":"Khadka","year":"2015","journal-title":"J\u00a0Glaucoma"},{"key":"10.1016\/j.ogla.2019.07.005_bib16","doi-asserted-by":"crossref","first-page":"e109400","DOI":"10.1371\/journal.pone.0109400","article-title":"Outcomes in Cochrane systematic reviews addressing four common eye conditions: an evaluation of completeness and comparability","volume":"9","author":"Saldanha","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ogla.2019.07.005_bib17","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1056\/NEJMsa1012065","article-title":"The ClinicalTrials.gov results database\u2014update and key issues","volume":"364","author":"Zarin","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ogla.2019.07.005_bib18","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s10384-012-0188-6","article-title":"Noncompliance with glaucoma medication in Korean patients: a multicenter qualitative study","volume":"57","author":"Park","year":"2013","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.ogla.2019.07.005_bib19","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/eye.2008.103","article-title":"Barriers to adherence with glaucoma medications: a qualitative research study","volume":"23","author":"Lacey","year":"2009","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ogla.2019.07.005_bib20","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/1472-6963-7-124","article-title":"Development of the conceptual framework for the Eye-Drop Satisfaction Questionnaire (EDSQ) in glaucoma using a qualitative study","volume":"7","author":"Nordmann","year":"2007","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.ogla.2019.07.005_bib21","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0277-9536(01)00169-1","article-title":"Learning to live with glaucoma: a qualitative study of diagnosis and the impact of sight loss","volume":"55","author":"Green","year":"2002","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.ogla.2019.07.005_bib22","first-page":"336","article-title":"Life experiences of patients with glaucoma: a phenomenological study","volume":"25","author":"Iyigun","year":"2017","journal-title":"J\u00a0Nurs Res"},{"key":"10.1016\/j.ogla.2019.07.005_bib23","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s12886-015-0119-7","article-title":"Living with glaucoma: a qualitative study of functional implications and patients\u2019 coping behaviours","volume":"15","author":"Glen","year":"2015","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.ogla.2019.07.005_bib24","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/IJG.0000000000000301","article-title":"Consensus on outcome measures for glaucoma effectiveness trials: results from a delphi and nominal group technique approaches","volume":"25","author":"Ismail","year":"2016","journal-title":"J\u00a0Glaucoma"},{"key":"10.1016\/j.ogla.2019.07.005_bib25","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.ophtha.2012.11.043","article-title":"How does glaucoma look?: patient perception of visual field loss","volume":"120","author":"Crabb","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2019.07.005_bib26","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00061198-200304000-00009","article-title":"Quality of life in glaucoma and its relationship with visual function","volume":"12","author":"Nelson","year":"2003","journal-title":"J\u00a0Glaucoma"},{"key":"10.1016\/j.ogla.2019.07.005_bib27","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1136\/bjo.83.5.546","article-title":"Patients\u2019 perception of visual impairment in glaucoma: a pilot study","volume":"83","author":"Nelson","year":"1999","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ogla.2019.07.005_bib28","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nrd.2017.25","article-title":"Accelerating development of scientific evidence for medical products within the existing US regulatory framework","volume":"16","author":"Sherman","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.ogla.2019.07.005_bib29","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1001\/jamaophthalmol.2017.2583","article-title":"Comparison of clinical trial and systematic review outcomes for the 4 most prevalent eye diseases","volume":"135","author":"Saldanha","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ogla.2019.07.005_bib30","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/IJG.0000000000000022","article-title":"Outcome measures in glaucoma: a systematic review of Cochrane reviews and protocols","volume":"24","author":"Ismail","year":"2015","journal-title":"J\u00a0Glaucoma"}],"container-title":["Ophthalmology Glaucoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589419619302479?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589419619302479?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T18:51:21Z","timestamp":1762887081000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589419619302479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S2589419619302479"],"URL":"https:\/\/doi.org\/10.1016\/j.ogla.2019.07.005","relation":{},"ISSN":["2589-4196"],"issn-type":[{"value":"2589-4196","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identifying Outcomes That Are Important to Patients with Ocular Hypertension or Primary Open-Angle Glaucoma","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Glaucoma","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ogla.2019.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}